AZN Operating Cash Flow Growth
AstraZeneca PLC Ordinary Shares · Operating Cash Flow Growth
AZN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported3.15%period ending
AZN TTM Cash from Operations YoY % (122.90% → 3.15%)
Year-over-year change
High-resolution chart · PNG
AZN operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 3.1467% | |
| 9.3295% | |
| 23.624% | |
| 33.5804% | |
| 21.0032% | |
| 34.9557% | |
| 14.6544% | |
| 9.3699% | |
| 8.7042% | |
| -0.1133% | |
| 5.4751% | |
| 17.3879% | |
| 33.6353% | |
| 33.7144% | |
| 64.481% | |
| 39.177% | |
| 18.1663% | |
| 10.1153% | |
| 24.2551% | |
| 44.9497% | |
| 76.2647% | |
| 88.6695% | |
| 61.6369% | |
| 14.615% | |
| 14.8555% | |
| 47.4062% | |
| 13.4072% | |
| 174.4788% | |
| 0.6003% | |
| -29.2239% | |
| -26.8306% | |
| -69.368% | |
| 1.8012% | |
| 10.1974% | |
| -13.6791% | |
| 64.7678% | |
| -15.7453% | |
| -33.7546% | |
| 24.6992% | |
| -40.0218% | |
| -23.125% | |
| -20.8657% | |
| -52.9045% | |
| -40.2781% | |
| -30.0495% | |
| -9.2346% | |
| -4.6216% | |
| -0.9781% | |
| -13.8048% | |
| -16.0005% | |
| 6.5055% | |
| 8.3833% | |
| 2.287% | |
| 1.807% | |
| -11.1623% | |
| -13.7512% | |
| -10.97% | |
| -31.0221% | |
| -26.7697% | |
| -25.799% | |
| -21.7508% | |
| -3.733% | |
| -9.0212% | |
| 7.2167% | |
| 14.1864% | |
| 31.1611% | |
| 34.2828% | |
| 16.7505% | |
| 13.5298% | |
| 11.2004% | |
| 16.4048% | |
| 34.1277% | |
| 15.5848% | |
| -7.8155% | |
| -2.3788% | |
| -10.587% | |
| 6.3623% | |
| 24.0439% | |
| 14.0887% | |
| 27.4249% | |
| 24.9109% | |
| 32.2745% | |
| 38.3747% | |
| 42.7596% | |
| 50.328% | |
| 44.3089% | |
| 42.6522% | |
| 4.485% | |
| -2.2524% | |
| -13.5701% | |
| -29.3193% | |
| -15.8201% | |
| -19.3053% | |
| -4.1448% | |
| 34.2214% | |
| 50.7923% | |
| 15.6063% | |
| 1.0806% | |
| 5.0821% | |
| 9.9291% |